Griffith & Werner’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$611K Buy
509
+98
+24% +$100K 0.29% 41
2026
Q1
$378K Hold
411
0.19% 50
2025
Q4
$442K Sell
411
-25
-6% -$23.9K 0.23% 45
2025
Q3
$422K Buy
+436
New +$324K 0.22% 47
2025
Q1
$379K Buy
459
+23
+5% +$19.1K 0.24% 47
2024
Q4
$337K Buy
+436
New +$361K 0.22% 50

Other funds holding LLY

Griffith & Werner's LLY Position: Q2 2026 in Review

Griffith & Werner increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $100K and bringing the position to 509 shares worth $611K. The position accounts for 0.29% of the portfolio, ranked #41.

Griffith & Werner first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Griffith & Werner held 509 shares of Eli Lilly worth $611K as of Q2 2026.
  • Griffith & Werner bought 98 Eli Lilly shares in Q2 2026, an estimated $100K.
  • Eli Lilly made up 0.29% of Griffith & Werner's portfolio in Q2 2026, its #41 holding.
  • Griffith & Werner first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Griffith & Werner's 13F filing for Q2 2026, filed 30 Jul 2026.